Evidence map›Paper›PMID 22022363›Full record

ArticlePloS one2011

Low concentrations of methamphetamine can protect dopaminergic cells against a larger oxidative stress injury: mechanistic study.

Amina El Ayadi, Michael J Zigmond

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Evaluation of Models of Parkinson's Disease.Frontiers in neuroscience · 2015
    Review
  10. Review
  11. Review
  12. Adaptation and sensitization to proteotoxic stress.Dose-response : a publication of International Hormesis Society · 2014
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Amina El AyadiPittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America. amelayad@utmb.edu
Michael J Zigmond
Institute for Neurodegenerative Disorders · US

Funding

USE AND DRUG DEPENDENT NEUROPROTECTION--TROPIC FACTORSP50NS019608 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZIGMOND, MICHAEL J · 2003 to 2009
$6.5M
Mechanisms of Exercise-Induced Protection and Rescue in Models of Dopamine LossR01NS070825 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOFFER, BARRY J, ZIGMOND, MICHAEL J · 2011 to 2014
$2.3M
NEUROPLASTICITY IN DAMAGED CATECHOLAMINERGIC SYSTEMSP01NS019608 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SESACK, SUSAN R · 1985 to 2002
$2.1M
NINDS NIH HHS NS19608NINDS NIH HHS P01 NS019608NINDS NIH HHS R01 NS070825
6 · The paper itself

Abstract

Mild stress can protect against a larger insult, a phenomenon termed preconditioning or tolerance. To determine if a low intensity stressor could also protect cells against intense oxidative stress in a model of dopamine deficiency associated with Parkinson disease, we used methamphetamine to provide a mild, preconditioning stress, 6-hydroxydopamine (6-OHDA) as a source of potentially toxic oxidative stress, and MN9D cells as a model of dopamine neurons. We observed that prior exposure to subtoxic concentrations of methamphetamine protected these cells against 6-OHDA toxicity, whereas higher concentrations of methamphetamine exacerbated it. The protection by methamphetamine was accompanied by decreased uptake of both [(3)H] dopamine and 6-OHDA into the cells, which may have accounted for some of the apparent protection. However, a number of other effects of methamphetamine exposure suggest that the drug also affected basic cellular survival mechanisms. First, although methamphetamine preconditioning decreased basal pERK1/2 and pAkt levels, it enhanced the 6-OHDA-induced increase in these phosphokinases. Second, the apparent increase in pERK1/2 activity was accompanied by increased pMEK1/2 levels and decreased activity of protein phosphatase 2. Third, methamphetamine upregulated the pro-survival protein Bcl-2. Our results suggest that exposure to low concentrations of methamphetamine cause a number of changes in dopamine cells, some of which result in a decrease in their vulnerability to subsequent oxidative stress. These observations may provide insights into the development of new therapies for prevention or treatment of PD.

Indexed as

AnimalsCell DeathCell LineCytoprotectionDopamineDopamine Plasma Membrane Transport ProteinsDopaminergic NeuronsDose-Response Relationship, DrugEnzyme ActivationExtracellular Signal-Regulated MAP KinasesJNK Mitogen-Activated Protein KinasesMethamphetamineMiceMice, Inbred C57BLNeuroprotective AgentsOxidative StressDopamineDopamine Plasma Membrane Transport ProteinsExtracellular Signal-Regulated MAP KinasesJNK Mitogen-Activated Protein KinasesMethamphetamineNeuroprotective AgentsOxidopamineProtein Phosphatase 2ProtonsProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2Superoxide Dismutase

Identifiers

PMID22022363
PMCPMC3192034
OpenAlexW2126525638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.